(Q33687798)

English

Long-term effect of latanoprost/timolol fixed combination in patients with glaucoma or ocular hypertension: A prospective, observational, noninterventional study

scientific article published on September 8, 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Long-term effect of latanoprost/timolol fixed combination in patients with glaucoma or ocular hypertension: a prospective, observational, noninterventional study (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Long-term effect of latanoprost/timolol fixed combination in patients with glaucoma or ocular hypertension: A prospective, observational, noninterventional study (English)

1 reference

10.1186/1471-2415-10-21

https://api.crossref.org/works/10.1186/1471-2415-10-21

9 July 2024

ocular hypertension

1 reference

based on heuristic

inferred from title

author name string

Oliver Schwenn

1

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Barbara Heckmann

2

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Claudia Guzy

3

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Paul J. Miller

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20825668

9 July 2024

language of work or name

1 reference

based on heuristic

inferred from title

publication date

8 September 2010

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

full work available at URL

https://bmcophthalmol.biomedcentral.com/counter/pdf/10.1186/1471-2415-10-21

Portable Document Format

online access status

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20825668

9 July 2024

http://www.biomedcentral.com/content/pdf/1471-2415-10-21.pdf

Portable Document Format

online access status

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20825668

9 July 2024

http://www.biomedcentral.com/1471-2415/10/21/abstract

online access status

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20825668

9 July 2024

http://www.biomedcentral.com/1471-2415/10/21

online access status

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20825668

9 July 2024

https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20825668/pdf/?tool=EBI

Portable Document Format

online access status

content deliverer

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20825668

9 July 2024

https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20825668/?tool=EBI

online access status

content deliverer

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20825668

9 July 2024

https://europepmc.org/articles/PMC2945977

online access status

content deliverer

Europe PubMed Central

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20825668

9 July 2024

https://europepmc.org/articles/PMC2945977?pdf=render

Portable Document Format

online access status

content deliverer

Europe PubMed Central

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20825668

9 July 2024

http://link.springer.com/article/10.1186/1471-2415-10-21/fulltext.html

1 reference

10.1186/1471-2415-10-21

https://api.crossref.org/works/10.1186/1471-2415-10-21

9 July 2024

http://link.springer.com/content/pdf/10.1186/1471-2415-10-21.pdf

Portable Document Format

1 reference

10.1186/1471-2415-10-21

https://api.crossref.org/works/10.1186/1471-2415-10-21

9 July 2024

http://link.springer.com/content/pdf/10.1186/1471-2415-10-21

1 reference

10.1186/1471-2415-10-21

https://api.crossref.org/works/10.1186/1471-2415-10-21

9 July 2024

BMC Ophthalmology

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

21

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

copyright license

Creative Commons Attribution 2.0 Generic

8 September 2010

1 reference

April 2022 Public Data File from Crossref

copyright status

1 reference

April 2022 Public Data File from Crossref

Fixed combination of latanoprost and timolol vs individual components for primary open-angle glaucoma or ocular hypertension: a randomized, double-masked study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945977

21 June 2018

Update on the mechanism of action of topical prostaglandins for intraocular pressure reduction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945977

21 June 2018

Adherence in glaucoma: objective measurements of once-daily and adjunctive medication use.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945977

21 June 2018

Short term efficacy and safety in glaucoma patients changed to the latanoprost 0.005%/timolol maleate 0.5% fixed combination from monotherapies and adjunctive therapies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945977

21 June 2018

A 12 week study comparing the fixed combination of latanoprost and timolol with the concomitant use of the individual components in patients with open angle glaucoma and ocular hypertension

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945977

21 June 2018

Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945977

21 June 2018

Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945977

21 June 2018

Latanoprost and timolol combination therapy vs monotherapy: one-year randomized trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945977

21 June 2018

Latanoprost administered once daily caused a maintained reduction of intraocular pressure in glaucoma patients treated concomitantly with timolol

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945977

21 June 2018

Additive effect of latanoprost, a prostaglandin F2 alpha analogue, and timolol in patients with elevated intraocular pressure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945977

21 June 2018

Compliance with topical timolol treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945977

21 June 2018

Timolol and facility of outflow.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945977

21 June 2018

The mechanism of timolol in lowering intraocular pressure. In the normal eye.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945977

21 June 2018

The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2415-10-21

21 January 2018

A 12-week, randomized, double-masked, multicenter study of the fixed combination of latanoprost and timolol in the evening versus the individual components

1 reference

https://api.crossref.org/works/10.1186%2F1471-2415-10-21

21 January 2018

A comparison of the fixed combination of latanoprost and timolol with its individual components

1 reference

https://api.crossref.org/works/10.1186%2F1471-2415-10-21

21 January 2018

Efficacy and safety of the fixed combinations latanoprost/timolol versus dorzolamide/timolol in patients with elevated intraocular pressure

1 reference

https://api.crossref.org/works/10.1186%2F1471-2415-10-21

21 January 2018

Tolerability, quality of life, and persistency of use in patients with glaucoma who are switched to the fixed combination of latanoprost and timolol.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2415-10-21

21 January 2018

Surveillance of glaucoma medical therapy in a Glasgow teaching hospital: 26 years' experience

1 reference

https://api.crossref.org/works/10.1186%2F1471-2415-10-21

21 January 2018

The impact of ocular adverse effects in patients treated with topical prostaglandin analogs: changes in prescription patterns and patient persistence.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2415-10-21

21 January 2018

Compliance Barriers in Glaucoma: A Systematic Classification

1 reference

https://api.crossref.org/works/10.1186%2F1471-2415-10-21

21 January 2018

The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration.The AGIS Investigators

1 reference

https://pubmed.ncbi.nlm.nih.gov/20825668

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Additivity of prostaglandin F2 alpha-1-isopropyl ester to timolol in glaucoma patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/20825668

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment for glaucoma: adherence by the elderly

1 reference

https://pubmed.ncbi.nlm.nih.gov/20825668

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Compliance in patients prescribed eyedrops for glaucoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/20825668

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Collaborative Normal-Tension Glaucoma Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/20825668

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intraocular pressure-lowering effects of latanoprost monotherapy versus latanoprost or pilocarpine in combination with timolol: a randomized, observer-masked multicenter study in patients with open-angle glaucoma. Italian Latanoprost Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/20825668

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of central corneal thickness, corneal curvature, and axial length on applanation tonometry

1 reference

https://pubmed.ncbi.nlm.nih.gov/20825668

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Investigative Ophthalmology Visual Science

6

16

623

author name string

TJ Zimmerman

publication date

1977

1 reference

10.1186/1471-2415-10-21

https://api.crossref.org/works/10.1186/1471-2415-10-21

9 July 2024

Identifiers

10.1186/1471-2415-10-21

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Dimensions Publication ID

0 references

release_jfe5dkowqfbmfpbzyrbhf5t664

1 reference

https://api.fatcat.wiki/v0/release/jfe5dkowqfbmfpbzyrbhf5t664

24 November 2022

based on heuristic

mapped directly with Wikidata item

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33687798&oldid=2205351093"